We serve Chemical Name:4-[3-amino-2-[(2-methylpropan-2-yl)oxycarbonyl]pyridin-4-yl]benzoic acid CAS:201810-35-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-[3-amino-2-[(2-methylpropan-2-yl)oxycarbonyl]pyridin-4-yl]benzoic acid

Chemical Name:4-[3-amino-2-[(2-methylpropan-2-yl)oxycarbonyl]pyridin-4-yl]benzoic acid
CAS.NO:201810-35-7
Synonyms:4-[3-amino-2-[(2-methylpropan-2-yl)oxycarbonyl]pyridin-4-yl]benzoic acid
Molecular Formula:C17H18N2O4
Molecular Weight:314.33600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:456.388ºC at 760 mmHg
Density:1.26g/cm3
Index of Refraction:1.603
PSA:102.51000
Exact Mass:314.12700
LogP:3.56550

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-[3-amino-2-[(2-methylpropan-2-yl)oxycarbonyl]pyridin-4-yl]benzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-[3-amino-2-[(2-methylpropan-2-yl)oxycarbonyl]pyridin-4-yl]benzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[3-amino-2-[(2-methylpropan-2-yl)oxycarbonyl]pyridin-4-yl]benzoic acid Use and application,4-[3-amino-2-[(2-methylpropan-2-yl)oxycarbonyl]pyridin-4-yl]benzoic acid technical grade,usp/ep/jp grade.


Related News: China’s basic chemical industry is developed, and the intermediate industry has also entered a mature stage. It is basically able to independently support the production needs of various domestic drug substances, which also brings cost advantages to Chinese drug substance companies. On the other hand, if there is insufficient supply of upstream products or price fluctuations, the sales of API products will also fluctuate in volume and price. 4-[3-amino-2-[(2-methylpropan-2-yl)oxycarbonyl]pyridin-4-yl]benzoic acid manufacturer Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly. 4-[3-amino-2-[(2-methylpropan-2-yl)oxycarbonyl]pyridin-4-yl]benzoic acid supplier The data will be updated at the upcoming 2019 ASH Annual Meeting next week. 4-[3-amino-2-[(2-methylpropan-2-yl)oxycarbonyl]pyridin-4-yl]benzoic acid vendor China’s basic chemical industry is developed, and the intermediate industry has also entered a mature stage. It is basically able to independently support the production needs of various domestic drug substances, which also brings cost advantages to Chinese drug substance companies. On the other hand, if there is insufficient supply of upstream products or price fluctuations, the sales of API products will also fluctuate in volume and price. 4-[3-amino-2-[(2-methylpropan-2-yl)oxycarbonyl]pyridin-4-yl]benzoic acid factory At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase.